BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

  June 5, 2025

   · 

  4 min read
• Press Releases

  Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

  June 5, 2025

   · 

  10 min read
• Press Releases

  Simulations Plus Releases ADMET Predictor® 13

  June 5, 2025

   · 

  4 min read
• Press Releases

  Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)

  June 5, 2025

   · 

  4 min read
• Press Releases

  Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC

  June 5, 2025

   · 

  5 min read
• Press Releases

  Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference

  June 5, 2025

   · 

  5 min read
• Press Releases

  CNS Pharmaceuticals’ Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit

  June 5, 2025

   · 

  4 min read
• Press Releases

  Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities

  June 5, 2025

   · 

  6 min read
• Press Releases

  Saundra Pelletier, Evofem Biosciences’ CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6

  June 5, 2025

   · 

  4 min read
• Press Releases

  Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium

  June 5, 2025

   · 

  7 min read